Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heteroarotinoids as anticancer agents

Heteroarotinoids as anticancer agents

US Patent 4833254 · Granted May 23, 1989

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chromane-substituted, tetrahydroquinoline-substituted and thiochromane-substitut2024
Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted2021
Antibody-SN-38 immunoconjugates with a CL2A linker2020
Antibody-SN-38 immunoconjugates with a CL2A linker2018
Antibody-SN-38 immunoconjugates with a CL2A linker2018
Antibody-SN-38 immunoconjugates with a CL2A linker2018
Antibody-SN-38 immunoconjugates with a CL2A linker2018
Antibody-SN-38 immunoconjugates with a CL2A linker2017
Antibody-SN-38 immunoconjugates with a CL2A linker2016
Antibody-SN-38 immunoconjugates with a CL2A linker2015
Process for the preparation of compositions for modulating a kinase cascade and 2012
Process for the preparation of compositions for modulating a kinase cascade and 2011